Literature DB >> 35123658

The hallmarks of cancer metabolism: Still emerging.

Natalya N Pavlova1, Jiajun Zhu2, Craig B Thompson3.   

Abstract

Metabolism of cancer cells is geared toward biomass production and proliferation. Since the metabolic resources within the local tissue are finite, this can lead to nutrient depletion and accumulation of metabolic waste. To maintain growth in these conditions, cancer cells employ a variety of metabolic adaptations, the nature of which is collectively determined by the physiology of their cell of origin, the identity of transforming lesions, and the tissue in which cancer cells reside. Furthermore, select metabolites not only serve as substrates for energy and biomass generation, but can also regulate gene and protein expression and influence the behavior of non-transformed cells in the tumor vicinity. As they grow and metastasize, tumors can also affect and be affected by the nutrient distribution within the body. In this hallmark update, recent advances are incorporated into a conceptual framework that may help guide further research efforts in exploring cancer cell metabolism.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35123658      PMCID: PMC8891094          DOI: 10.1016/j.cmet.2022.01.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  214 in total

1.  Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

Authors:  Thomas P Lynch; Christina M Ferrer; S RaElle Jackson; Kristina S Shahriari; Keith Vosseller; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.

Authors:  Pei-Hsuan Chen; Ling Cai; Kenneth Huffman; Chendong Yang; Jiyeon Kim; Brandon Faubert; Lindsey Boroughs; Bookyung Ko; Jessica Sudderth; Elizabeth A McMillan; Luc Girard; Dong Chen; Michael Peyton; Misty D Shields; Bo Yao; David S Shames; Hyun Seok Kim; Brenda Timmons; Ikuo Sekine; Rebecca Britt; Stephanie Weber; Lauren A Byers; John V Heymach; Jing Chen; Michael A White; John D Minna; Guanghua Xiao; Ralph J DeBerardinis
Journal:  Mol Cell       Date:  2019-09-26       Impact factor: 17.970

3.  Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.

Authors:  Deanna N Edwards; Verra M Ngwa; Ariel L Raybuck; Shan Wang; Yoonha Hwang; Laura C Kim; Sung Hoon Cho; Yeeun Paik; Qingfei Wang; Siyuan Zhang; H Charles Manning; Jeffrey C Rathmell; Rebecca S Cook; Mark R Boothby; Jin Chen
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

4.  The Acidic Tumor Microenvironment as a Driver of Cancer.

Authors:  Ebbe Boedtkjer; Stine F Pedersen
Journal:  Annu Rev Physiol       Date:  2019-11-15       Impact factor: 19.318

Review 5.  Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.

Authors:  Barbara Delage; Dean A Fennell; Linda Nicholson; Iain McNeish; Nicholas R Lemoine; Tim Crook; Peter W Szlosarek
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

6.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

7.  Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions.

Authors:  Orianne Olivares; Jared R Mayers; Victoire Gouirand; Margaret E Torrence; Tristan Gicquel; Laurence Borge; Sophie Lac; Julie Roques; Marie-Noëlle Lavaut; Patrice Berthezène; Marion Rubis; Veronique Secq; Stéphane Garcia; Vincent Moutardier; Dominique Lombardo; Juan Lucio Iovanna; Richard Tomasini; Fabienne Guillaumond; Matthew G Vander Heiden; Sophie Vasseur
Journal:  Nat Commun       Date:  2017-07-07       Impact factor: 14.919

8.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

9.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

10.  Hypoxia Induces Production of L-2-Hydroxyglutarate.

Authors:  Andrew M Intlekofer; Raymond G Dematteo; Sriram Venneti; Lydia W S Finley; Chao Lu; Alexander R Judkins; Ariën S Rustenburg; Patrick B Grinaway; John D Chodera; Justin R Cross; Craig B Thompson
Journal:  Cell Metab       Date:  2015-07-23       Impact factor: 31.373

View more
  34 in total

1.  Extracellular vesicles derived from Lactobacillus plantarum restore chemosensitivity through the PDK2-mediated glucose metabolic pathway in 5-FU-resistant colorectal cancer cells.

Authors:  JaeJin An; Eun-Mi Ha
Journal:  J Microbiol       Date:  2022-07-04       Impact factor: 3.422

Review 2.  Metabolic changes during prostate cancer development and progression.

Authors:  Alicia-Marie K Beier; Martin Puhr; Matthias B Stope; Christian Thomas; Holger H H Erb
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-23       Impact factor: 4.322

3.  Comparison of dual mTORC1/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics.

Authors:  Zhitao Ni; Shaolin Xu; Zheng Yu; Zhongjiang Ye; Rongqi Li; Chuang Chen; Jianhui Yang; Huamin Liu; Ziye Zhou; Xiuhua Zhang
Journal:  Invest New Drugs       Date:  2022-09-05       Impact factor: 3.651

4.  Diet and Exercise in Cancer Metabolism.

Authors:  Jason W Locasale
Journal:  Cancer Discov       Date:  2022-10-05       Impact factor: 38.272

Review 5.  Transcriptional control of energy metabolism by nuclear receptors.

Authors:  Charlotte Scholtes; Vincent Giguère
Journal:  Nat Rev Mol Cell Biol       Date:  2022-05-16       Impact factor: 113.915

Review 6.  Emerging roles of cystathionine β-synthase in various forms of cancer.

Authors:  Kelly Ascenção; Csaba Szabo
Journal:  Redox Biol       Date:  2022-05-10       Impact factor: 10.787

Review 7.  Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences.

Authors:  Ana Cardeña-Gutiérrez; Mónica López Barahona
Journal:  Front Med (Lausanne)       Date:  2022-06-14

8.  Editorial: Metabolite and Nutrient Transporters in Cancer-Cell Metabolism: Role in Cancer Progression and Metastasis.

Authors:  Vadivel Ganapathy; Sebastian Haferkamp; Eric K Parkinson; Maria E Mycielska
Journal:  Front Cell Dev Biol       Date:  2022-04-25

9.  Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells.

Authors:  Ahmet Hatipoglu; Deepak Menon; Talia Levy; Maria A Frias; David A Foster
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

10.  Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma.

Authors:  Laura A Evans; Emilie A Anderson; Erik Jessen; Bharat Nandakumar; Ezgi Atilgan; Dragan Jevremovic; Taro Hitosugi; Rafael Fonseca; Shaji K Kumar; Wilson I Gonsalves
Journal:  Am J Hematol       Date:  2022-05-06       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.